<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Educational material from Pfizer &#8211; BJC TV</title>
	<atom:link href="https://tv.bjcardio.co.uk/educational-material-from-pfizer/feed/" rel="self" type="application/rss+xml" />
	<link>https://tv.bjcardio.co.uk</link>
	<description>Short video updates for cardiologists</description>
	<lastBuildDate>Tue, 31 Mar 2026 08:18:39 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://tv.bjcardio.co.uk/wp-content/uploads/2023/06/cropped-favicon-32x32.png</url>
	<title>Educational material from Pfizer &#8211; BJC TV</title>
	<link>https://tv.bjcardio.co.uk</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>The barriers to early diagnosis of cardiac amyloidosis in women</title>
		<link>https://tv.bjcardio.co.uk/featured-videos-1/the-barriers-to-early-diagnosis-of-cardiac-amyloidosis-in-women/</link>
		
		<dc:creator><![CDATA[jleiwy@omniamed.com]]></dc:creator>
		<pubDate>Tue, 31 Mar 2026 08:18:37 +0000</pubDate>
				<category><![CDATA[Educational material from Pfizer]]></category>
		<category><![CDATA[Featured videos #1]]></category>
		<category><![CDATA[Exclude categories]]></category>
		<category><![CDATA[Exclude-carousel]]></category>
		<category><![CDATA[Exclude-videolistingpage]]></category>
		<category><![CDATA[Featured Videos #1]]></category>
		<category><![CDATA[Pfizer 2026]]></category>
		<category><![CDATA[SidebarExclude]]></category>
		<category><![CDATA[Sponsored]]></category>
		<guid isPermaLink="false">https://tv.bjcardio.co.uk/?p=11313</guid>

					<description><![CDATA[In this short video, Professor Fontana discusses the barriers women face in the diagnosis of cardiac amyloidosis.]]></description>
										<content:encoded><![CDATA[
<h5 class="wp-block-heading">Speaker</h5>



<p class="wp-block-paragraph"><strong>Professor Marianna Fontana</strong>, Professor of Cardiology and Honorary Consultant Cardiologist at the National Amyloidosis Centre, University College London</p>



<p class="wp-block-paragraph">For more expert-led non-promotional content on heart failure, cardiac amyloidosis and ATTR-CM, please visit the <a href="https://www.pfizermedical.co.uk/therapy-areas/cardiovascular" rel="nofollow noopener" target="_blank">Pfizer Medical website</a>. Clicking this link will redirect you to the Pfizer Medical website, a non-promotional website developed and funded by Pfizer Ltd. for UK healthcare professionals.</p>



<p class="wp-block-paragraph">Abbreviation:<br>ATTR-CM: Transthyretin amyloid cardiomyopathy.</p>



<p style="color: black; font-size: 14px; margin-top: 20px;">PP-UNP-GBR-14079 | March 2026</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>British Society of Echocardiography guideline for the TTE assessment of cardiac amyloidosis and the role of ECHO in monitoring disease progression in cardiac amyloidosis</title>
		<link>https://tv.bjcardio.co.uk/featured-videos-1/british-society-of-echocardiography-guideline-for-the-tte-assessment-of-cardiac-amyloidosis-and-the-role-of-echo-in-monitoring-disease-progression-in-cardiac-amyloidosis/</link>
					<comments>https://tv.bjcardio.co.uk/featured-videos-1/british-society-of-echocardiography-guideline-for-the-tte-assessment-of-cardiac-amyloidosis-and-the-role-of-echo-in-monitoring-disease-progression-in-cardiac-amyloidosis/#comments</comments>
		
		<dc:creator><![CDATA[jleiwy@omniamed.com]]></dc:creator>
		<pubDate>Tue, 31 Mar 2026 08:16:57 +0000</pubDate>
				<category><![CDATA[Educational material from Pfizer]]></category>
		<category><![CDATA[Featured videos #1]]></category>
		<category><![CDATA[Exclude categories]]></category>
		<category><![CDATA[Exclude-videolistingpage]]></category>
		<category><![CDATA[Featured Videos #1]]></category>
		<category><![CDATA[Pfizer 2026]]></category>
		<category><![CDATA[Pfizer amyloidosis series 2026]]></category>
		<category><![CDATA[SidebarExclude]]></category>
		<category><![CDATA[Sponsored]]></category>
		<guid isPermaLink="false">https://tv.bjcardio.co.uk/?p=11298</guid>

					<description><![CDATA[In this short video, Dr Moody discusses the British Society of Echocardiography guidelines for the TTE assessment of cardiac amyloidosis, and monitoring disease progression.]]></description>
										<content:encoded><![CDATA[
<h5 class="wp-block-heading">Speaker</h5>



<p class="wp-block-paragraph"><strong>Dr William E Moody,</strong> Consultant Cardiologist, Queen Elizabeth Hospital, Birmingham</p>



<p class="wp-block-paragraph">For more expert-led non-promotional content on heart failure, cardiac amyloidosis and transthyretin amyloid cardiomyopathy, please visit the <a href="https://www.pfizermedical.co.uk/therapy-areas/cardiovascular" rel="nofollow noopener" target="_blank">Pfizer Medical website</a>. Clicking this link will redirect you to the Pfizer Medical website, a non-promotional website developed and funded by Pfizer Ltd. for UK healthcare professionals.</p>



<h5 class="wp-block-heading">Reference</h5>



<p class="wp-block-paragraph">Moody, William E <em>et al</em>. “British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of cardiac amyloidosis.” Echo research and practice vol. 10,1 13. 31 Aug. 2023, doi:10.1186/s44156-023-00028-7</p>



<p class="wp-block-paragraph">Abbreviations:<br>ECHO: echocardiography; TTE: transthoracic echocardiography.</p>



<p style="color: black; font-size: 14px; margin-top: 20px;">PP-UNP-GBR-14075 | March 2026</p>



<p class="wp-block-paragraph"></p>
]]></content:encoded>
					
					<wfw:commentRss>https://tv.bjcardio.co.uk/featured-videos-1/british-society-of-echocardiography-guideline-for-the-tte-assessment-of-cardiac-amyloidosis-and-the-role-of-echo-in-monitoring-disease-progression-in-cardiac-amyloidosis/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
	</channel>
</rss>
